Phosphoribosyl-diphosphate synthetase

Arnvig, K, Hove-Jensen, B., and Switzer, R.L, (1990) Purification and properties of phosphoribosyl-diphosphate synthetase from Bacillus subtilis. Eur. J. Biochent, 192 (1), 195-200,... 

Phosphoribosyl-diphosphate synthetase catalyzes the phosphorylation of ribose 5-phosphate during the biosynthesis of pyrimidine nucleotides. 

This enzyme [EC 2.7.6.1], also known as phosphoribosyl pyrophosphate synthetase, catalyzes the reaction of ATP with D-ribose 5-phosphate to produce AMP and 5-phospho-a-D-ribose 1-diphosphate. dATP can also function as a substrate. 

Didanosine is a synthetic purine nucleoside analog that inhibits the activity of reverse transcriptase in HIV-1, HIV-2, other retroviruses and zidovudine-resistant strains. A nucleobase carrier helps transport it into the cell where it needs to be phosphorylated by 5 -nucleoiidase and inosine 5 -monophosphate phosphotransferase to didanosine S -monophosphate. Adenylosuccinate synthetase and adenylosuccinate lyase then convert didanosine 5 -monophosphate to dideoxyadenosine S -monophosphate, followed by its conversion to diphosphate by adenylate kinase and phosphoribosyl pyrophosphate synthetase, which is then phosphorylated by creatine kinase and phosphoribosyl pyrophosphate synthetase to dideoxyadenosine S -triphosphate, the active reverse transcriptase inhibitor. Dideoxyadenosine triphosphate inhibits the activity of HIV reverse transcriptase by competing with the natural substrate, deoxyadenosine triphosphate, and its incorporation into viral DNA causes termination of viral DNA chain elongation. It is 10-100-fold less potent than zidovudine in its antiviral activity, but is more active than zidovudine in nondividing and quiescent cells. At clinically relevant doses, it is not toxic to hematopoietic precursor cells or lymphocytes, and the resistance to the drug results from site-directed mutagenesis at codons 65 and 74 of viral reverse transcriptase. 

The hypE proteins are 302-376 residues long and appear to consist of three domains. Domain 1 shows sequence identity to a domain from phosphoribosyl-aminoimida-zole synthetase which is involved in the fifth step in de novo purine biosynthesis and to a domain in thiamine phosphate kinase which is involved in the synthesis of the cofactor thiamine diphosphate (TDP). TDP is required by enzymes which cleave the bond adjacent to carbonyl groups, e.g. phosphoketolase, transketolase or pyruvate decarboxylase. Domain 2 also shows identity to a domain found in thiamine phosphate kinase. Domain 3 appears to be unique to the HypF proteins. 

Aspartate carbamyltransferase 2 dihydroorotase 3 orotate reductase 4 orotate phosphoribosyl-transferase 5 orotidine-5 -phosphate decarboxylase 6 cytidylate kinase, nucleotide diphosphate kinase 7 cytidine triphosphate synthetase 8 nucleoside monophosphate kinase, ribonucleoside diphosphate reductase, phosphatase 9 thymidylate synthase... 

---